Forbes Alexandria, President & CEO of MeiraGTx Holdings plc (NASDAQ:MGTX), sold 62,000 ordinary shares on May 19, 2026, according to a recent Form 4 filing. The total value of the shares sold amounted to $568,540.
The shares were sold in multiple transactions at prices ranging from $8.96 to $9.32 per share, with a weighted average sale price of $9.17. These sales were executed under a Rule 10b5-1 trading plan adopted on November 18, 2025.
The insider sale comes as MeiraGTx stock has delivered a 66% return over the past year, currently trading at $9.13. According to Bond.az analysis, the stock appears slightly overvalued relative to its Fair Value estimate. Analyst price targets range from $19 to $50.
The company holds a "Fair" financial health score of 2.38, though Bond.az Tips indicate profitability challenges remain, with analysts not anticipating profits this year.
Following these transactions, Ms. Forbes directly holds 1,387,695 ordinary shares of MeiraGTx.
In other news, MeiraGTx completed a strategic collaboration with Hologen Limited focusing on gene therapies for Parkinson's disease and genetic obesity disorders. The company also priced an underwritten public offering expected to raise approximately $100 million.
Piper Sandler raised its price target for MeiraGTx to $30, maintaining an Overweight rating. RBC Capital increased its target to $24, and H.C. Wainwright reiterated a Buy rating with a $20 target.
